HER2 Expression in Gastric Cancer: Rare, Heterogeneous and of No Prognostic Value – Conclusions from 924 Cases of Two Independent Series
oleh: Heike Grabsch, Shivan Sivakumar, Sally Gray, Helmut E. Gabbert, Wolfram Müller
| Format: | Article |
|---|---|
| Diterbitkan: | Hindawi Limited 2010-01-01 |
Deskripsi
Background: Patients with gastric cancer (GC) have a poor survival and biologicals such as Trastuzumab have not been used routinely in these patients. Existing data on HER2 expression and its clinical relevance in GC are still limited and controversial.